Hjem › Akut myelogen leukemi › Virginia › Richmond
Kliniske studier for Akut myelogen leukemi i Richmond, VA
12 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Richmond (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- VCU Massey Comprehensive Cancer Center, Richmond
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- og 3 flere
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
RekruttererFase 3
- Virginia Commonwealth University - Massey Cancer Center, Richmond
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- VCU Massey Comprehensive Cancer Center, Richmond
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- VCU Massey Comprehensive Cancer Center, Richmond
Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN
RekruttererFase 2
- Virginia Commonwealth University, Richmond
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekruttererFase 3
- VCU Massey Comprehensive Cancer Center, Richmond
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- VCU Massey Comprehensive Cancer Center, Richmond
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
RekruttererFase 3
- Children's Hospital of Richmond at Virginia Commonwealth University, Richmond
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- Virginia Commonwealth University, Richmond
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
RekruttererFase 4
- Virginia Commonwealth University, Richmond
Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation
RekruttererFase 1
- Virginia Commonwealth University, Richmond
Akut myelogen leukemi-studier i andre byer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Seattle, WA41 studier
- Baldwin Park, CA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA31 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
Andre studier i Richmond
- Brystkreft26 studier
- Ikke-småcellet lungekreft25 studier
- Prostatakreft19 studier
- Hjertesvikt16 studier
- Lungekreft14 studier
- Kardiovaskulær sykdom13 studier
- Kolorektal kreft13 studier
- Steatotisk leversykdom12 studier
- Metastatisk kreft12 studier
- Plateepitelcancer i hode og hals12 studier
- Melanom11 studier
- Fedme11 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.